Mirae Asset Global Etfs Holdings Ltd. Protagonist Therapeutics, Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 35,841 shares of PTGX stock, worth $2.32 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,841
Previous 37,403
4.18%
Holding current value
$2.32 Million
Previous $1.81 Million
9.51%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PTGX
# of Institutions
297Shares Held
67.4MCall Options Held
290KPut Options Held
318K-
Farallon Capital Management LLC San Francisco, CA6.17MShares$400 Million1.53% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$373 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.76MShares$373 Million4.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.36MShares$283 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.25MShares$210 Million6.36% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $3.18B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...